{"id":13849,"date":"2017-09-20T09:17:28","date_gmt":"2017-09-20T09:17:28","guid":{"rendered":"https:\/\/celonpharma.com\/?p=13849"},"modified":"2017-09-20T09:17:28","modified_gmt":"2017-09-20T09:17:28","slug":"steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2","status":"publish","type":"post","link":"https:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/","title":{"rendered":"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017."},"content":{"rendered":"<p>The Company published its Periodic Report for the 1 half of 2017.<\/p>\n<ul>\n<li>The total value of sales generated by the Company in the first half of 2017 amounted to 57 million net, whereas net profit to over 13 million.<\/li>\n<li>In terms of volume, the sales of specialised medicinal products which are Polish market leaders in their respective therapeutic categories reached the growth rate of 10%.<\/li>\n<li>The export value is in line with the Company\u2019s expectations and shows prospect for growth in subsequent months of 2017;<\/li>\n<li>Promising results of R&#038;D projects in the field of innovative therapies will enable i.a. a formal launching of the clinical development for 3 drug candidates by the end of 2017.<\/li>\n<\/ul>\n<p>We also invite you to read the\u00a0report\u00a0and\u00a0material with a commentary of the Company\u2019s Management Board.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Company published its Periodic Report for the 1 half of 2017. The total value of sales generated by the Company in the first half of 2017 amounted to 57 million net, whereas net profit to over 13 million. In terms of volume, the sales of specialised medicinal products which are Polish market leaders in<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/\" title=\"ReadSteady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017.\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[26],"tags":[],"class_list":["post-13849","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.8.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017. - CelonGROUP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017. - CelonGROUP\" \/>\n<meta property=\"og:description\" content=\"The Company published its Periodic Report for the 1 half of 2017. The total value of sales generated by the Company in the first half of 2017 amounted to 57 million net, whereas net profit to over 13 million. In terms of volume, the sales of specialised medicinal products which are Polish market leaders inRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/\" \/>\n<meta property=\"og:site_name\" content=\"CelonGROUP\" \/>\n<meta property=\"article:published_time\" content=\"2017-09-20T09:17:28+00:00\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/\",\"url\":\"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/\",\"name\":\"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017. - CelonGROUP\",\"isPartOf\":{\"@id\":\"https:\/\/celon.group\/en\/#website\"},\"datePublished\":\"2017-09-20T09:17:28+00:00\",\"author\":{\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\"},\"breadcrumb\":{\"@id\":\"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/celon.group\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/celon.group\/en\/#website\",\"url\":\"https:\/\/celon.group\/en\/\",\"name\":\"CelonGROUP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/celon.group\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf\",\"name\":\"Ma\u0142gorzata Siewierska\",\"url\":\"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017. - CelonGROUP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/","og_locale":"en_US","og_type":"article","og_title":"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017. - CelonGROUP","og_description":"The Company published its Periodic Report for the 1 half of 2017. The total value of sales generated by the Company in the first half of 2017 amounted to 57 million net, whereas net profit to over 13 million. In terms of volume, the sales of specialised medicinal products which are Polish market leaders inRead more &raquo;","og_url":"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/","og_site_name":"CelonGROUP","article_published_time":"2017-09-20T09:17:28+00:00","author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/","url":"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/","name":"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017. - CelonGROUP","isPartOf":{"@id":"https:\/\/celon.group\/en\/#website"},"datePublished":"2017-09-20T09:17:28+00:00","author":{"@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf"},"breadcrumb":{"@id":"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/celon.group\/en\/2017\/09\/20\/steady-income-and-positive-sales-dynamics-of-celon-pharma-s-a-in-the-first-half-of-2017-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celon.group\/en\/"},{"@type":"ListItem","position":2,"name":"Steady income and positive sales dynamics of Celon Pharma S.A. in the first half of 2017."}]},{"@type":"WebSite","@id":"https:\/\/celon.group\/en\/#website","url":"https:\/\/celon.group\/en\/","name":"CelonGROUP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celon.group\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celon.group\/en\/#\/schema\/person\/e0ffc863fc928f3fd9bd67757492badf","name":"Ma\u0142gorzata Siewierska","url":"https:\/\/celon.group\/en\/author\/malgorzata-siewierska\/"}]}},"_links":{"self":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/13849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/comments?post=13849"}],"version-history":[{"count":0,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/posts\/13849\/revisions"}],"wp:attachment":[{"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/media?parent=13849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/categories?post=13849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celon.group\/en\/wp-json\/wp\/v2\/tags?post=13849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}